Megadeals Are Back: Why Execution Risk Must Move into the Deal Thesis Before Signing
Megadeals are back on the investment banking agenda. Large strategic transactions are returning as companies reposition around AI, infrastructure, supply chains, portfolio focus, scale, and global growth. But the larger the transaction, the more dangerous it is to treat execution risk as a post-signing issue.
For investment banking leaders, the question is not simply whether a megadeal has strategic logic. Many do. The question is whether the deal thesis includes enough operating reality before signing: integration complexity, management capacity, synergy feasibility, customer and supplier risk, regulatory timing, cross-border execution, stranded cost, and the practical path from announcement to measurable enterprise value.
Megadeals create value only when execution risk is built into the thesis before signing, not discovered after the transaction becomes public.
The Megadeal Cycle Has Reopened
Reuters’ April 2026 report, “Record megadeals in first quarter set the pace for global M&A gains,” showed how sharply the market shifted. Global M&A exceeded $1.2 trillion in the first quarter of 2026, and Reuters reported 22 deals above $10 billion, a quarterly record. The report also noted that AI and Big Tech transactions helped drive activity, while cross-border M&A rose 47% to $454.7 billion.
That backdrop creates opportunity for investment banks. It also raises the cost of weak execution assumptions. A small transaction can sometimes absorb modest integration slippage. A megadeal can magnify it across systems, geographies, product lines, customer relationships, regulatory obligations, capital structure, talent retention, and management attention.
The market may reward strategic boldness, but it punishes operational ambiguity. When a transaction is large enough to reshape a company, the execution plan becomes part of the investment thesis itself.
Strategic Rationale Can Outrun Integration Reality
Megadeals are often justified by compelling strategic logic: category leadership, scale economics, product adjacency, geographic reach, technology access, customer base, supply-chain control, or portfolio transformation. Those reasons may be valid, but they do not answer the operating question. Can the combined enterprise actually capture the value within the timing, cost, and risk assumptions presented to boards, lenders, shareholders, and regulators?
Integration reality is usually more complicated than the transaction narrative. Systems may not align. Sales forces may overlap but serve different customer segments. Procurement synergies may depend on supplier qualification or product redesign. Manufacturing or service networks may require footprint decisions. Shared services may create disruption before savings. Cultural differences may slow decision-making. Regulatory approvals may force sequencing that changes the integration path.
For investment banking advisers, execution risk should be brought into the thesis early enough to affect the advice. It should influence valuation, structure, timing, communications, financing, governance, and readiness planning before signing, not simply become a Day One agenda item.
Synergy Numbers Need Operating Mechanisms
Synergies are central to many megadeal models, but the number is only as strong as the mechanism behind it. Cost synergies may depend on procurement leverage, headcount rationalization, footprint consolidation, systems integration, duplicate-function removal, or vendor renegotiation. Revenue synergies may depend on cross-selling, channel access, product bundling, customer retention, or pricing discipline.
Each mechanism has timing, risk, and ownership. Procurement savings may require category expertise and contract timing. Workforce changes may require labor, legal, and cultural sequencing. Systems savings may require migration risk. Revenue synergies may require seller behavior, customer permission, service capability, and clear incentives. If those mechanisms are not understood, synergy estimates can become a valuation input without a reliable path to capture.
The strongest megadeal diligence connects the synergy case to the operating plan. It identifies which synergies are controllable, which depend on customer or regulatory behavior, which require capital, which create disruption risk, and which should be excluded or discounted until execution evidence improves.
Cross-Border Complexity Requires More Than Legal Readiness
Reuters reported that cross-border M&A rose sharply in the first quarter of 2026. Cross-border transactions can create strategic value, but they also increase execution complexity. Tariffs, trade rules, tax structures, workforce practices, local management capabilities, customer expectations, regulatory timing, supplier exposure, and foreign-exchange effects can all change the economics of the deal.
Legal, tax, and regulatory diligence are essential, but they are not enough. Cross-border execution also requires operating diligence: how products move, how customers are served, how decisions are made, how local teams report performance, how working capital behaves, how cost savings will be captured, and how leadership will manage across time zones, cultures, and systems.
A cross-border megadeal can fail quietly if integration governance is built around legal closing rather than operating control. The question is not only whether the transaction can be approved. It is whether the combined business can operate better after approval.
Financing and Market Scrutiny Raise the Standard
Reuters reported in April 2026 that Wall Street’s biggest banks still expected 2026 to be a strong deal year, even as market volatility and geopolitical unrest added caution. That context matters because megadeals require confidence from several stakeholders at once: boards, lenders, shareholders, ratings agencies, regulators, management teams, employees, and customers.
The S&P Global Ratings May 2026 leveraged finance update described encouraging discipline in recent deals while identifying lingering default risk in legacy vintages. For large transactions, that environment puts pressure on deal teams to show that leverage, liquidity, synergy timing, integration cost, and downside cases are supported by operating evidence.
Megadeals can be financed and announced on a strategic story, but they are judged over time by delivery. If execution risk is underestimated before signing, the market will eventually price it through missed synergy targets, slower deleveraging, integration charges, customer attrition, or loss of management credibility.
Execution Findings Should Change Deal Decisions
Execution diligence has the greatest value when it affects decisions before the transaction is signed. If findings merely become a post-signing checklist, they may arrive too late to shape the economics of the deal. The strongest transaction teams use execution findings to change valuation, synergy phasing, financing assumptions, governance design, communications planning, and integration sequencing.
That discipline is especially important in megadeals because the range of possible outcomes is wide. A synergy may be real but slow. A cost action may be possible but disruptive. A customer relationship may be valuable but fragile. A management team may be strong in the current business but untested at the scale or complexity the transaction will create. Those distinctions matter before the deal is announced.
Investment banking advisers can help clients make these tradeoffs explicit. The goal is not to create friction for its own sake. It is to ensure that transaction terms, market messaging, lender materials, board approvals, and post-signing execution plans all reflect the same operating view of the deal.
This also strengthens credibility after announcement. When the market asks how value will be captured, leadership can point to a plan that was built into the thesis rather than improvised after the fact. That matters in large transactions, where investor patience can narrow quickly if early execution signals are unclear.
The same principle applies inside the combined organization. Employees and operating leaders need to see that the deal is not only a corporate announcement but a coordinated execution agenda. Without that clarity, local teams may protect legacy routines, delay difficult decisions, or interpret the transaction through functional priorities rather than enterprise value creation.
A clear execution thesis gives the organization a practical roadmap for what changes, what stays stable, and what must be measured first. It turns scale into coordinated action rather than distributed uncertainty across the combined enterprise from Day One.
The Brooks International Perspective
From Brooks International’s perspective, megadeals require execution diligence before signing and execution deployment after signing. The two cannot be separated. A transaction model that includes synergy, margin, cash, integration, and value creation assumptions should also include the operating actions required to realize them.
Brooks International supports investment banking stakeholders by pressure-testing execution risk, assessing management capability, identifying operational and commercial diligence issues, validating value realization assumptions, and helping deploy the operating cadence needed to convert the transaction plan into measurable performance.
The objective is to create confidence that the deal thesis can survive contact with the operating environment. That means understanding not only why the deal should happen, but how the value will actually be captured.
What Investment Banking Leaders Should Be Asking Now
The leadership agenda should test whether execution risk is embedded in the megadeal thesis before signing.
• Which integration, synergy, customer, supplier, systems, workforce, and regulatory assumptions are most critical to value realization?
• Are synergy estimates tied to named operating mechanisms, owners, timing, and dependencies?
• How would delay in regulatory approval, systems integration, or management alignment affect the financial model?
• Which cross-border or multi-site operating differences could slow value capture?
• What execution risks should affect valuation, financing, governance, communications, or post-signing deployment?
• Can the leadership team explain how the first 100 days will protect momentum without losing sight of multi-year value capture?
The Leadership Imperative
Megadeals are returning because companies are making bigger strategic moves. That makes execution discipline more important, not less. The larger the transaction, the more damaging it is to discover after signing that the operating model cannot deliver the thesis at the expected speed.
For investment banking leaders, the mandate is clear: move execution risk into the deal thesis before signing. The best megadeals will not be defined only by size or strategic ambition. They will be defined by whether leaders can convert the announced rationale into operating performance that the market can see.
